Suggestions
Mark Sims
Vice President - Head of Oncology Business Unit, CANADA at AstraZeneca
Mark Sims is a seasoned professional in the bio-pharmaceutical industry with over 17 years of experience in leadership, strategy development, operational marketing, and sales execution. He is dedicated to driving innovation in healthcare to enhance patient care standards, particularly in the area of cancer treatment. Mark currently serves as the Vice President and Head of Oncology Business Unit in Canada at AstraZeneca. He has held prominent roles in various organizations, including leading positions at Novartis and Idenix Pharmaceuticals, Inc. Mark holds a Bachelor of Business Administration from McMaster University and has also studied at the Thunderbird School of Global Management.